We are thrilled to announce that our team from NWEH, led by CEO Jonathan Wogel, Head of Pharmacovigilance and Regulatory Services, Claire Williams, and Commercial Director Steve MacAleese, will be attending the ACDM 2023 conference in Barcelona. This annual conference brings together experts in data management and clinical research to discuss the latest developments in the field.
We are especially excited that Claire Williams will be leading the discussion on “An innovative approach to the monitoring, detecting, and reporting of Adverse Events (AE) in clinical trials.” Using electronic healthcare records for this purpose has shown great promise in improving patient safety, and we believe it will be a game-changer for the industry.
Our team has been working hard to develop and implement this approach, and we are eager to share our findings with others in the field. We invite everyone attending the conference to come and meet us and learn more about our innovative approach to delivering safer clinical trials.
We are proud to be part of such an important event, and we look forward to connecting with others in the industry, sharing our expertise, and learning from the best. See you in Barcelona!
Lear more about the event at: https://acdmconference.org/acdm23-programme/